Algert Global LLC Rigel Pharmaceuticals Inc Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $71,048 - $338,273	-106,042 Reduced 73.85%	37,550 $42,000
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $318,774 - $495,392	143,592 New	143,592 $429,000
Q2 2021 Aug 13, 2021	SELL	$3.09 - $4.54 $46,937 - $68,962	-15,190 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$3.35 - $4.93 $50,886 - $74,886	15,190 New	15,190 $52,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.96B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.